Connor, Clark & Lunn Investment Management Ltd. Harvard Bioscience Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 200,032 shares of HBIO stock, worth $262,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200,032

Previous 180,006 11.13%

Holding current value

$262,041

Previous $484,000 12.81%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$2.02 - $2.82 $40,452 - $56,473	20,026 Added 11.13%	200,032 $422,000
Q3 2024 Nov 08, 2024	BUY	$2.64 - $3.54 $78,162 - $104,808	29,607 Added 19.69%	180,006 $484,000
Q2 2024 Aug 09, 2024	BUY	$2.77 - $4.63 $17,572 - $29,372	6,344 Added 4.4%	150,399 $428,000
Q1 2024 May 09, 2024	BUY	$4.02 - $5.39 $10,315 - $13,830	2,566 Added 1.81%	144,055 $610,000
Q4 2023 Feb 09, 2024	SELL	$4.0 - $5.49 $81,320 - $111,611	-20,330 Reduced 12.56%	141,489 $756,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $252,696 - $367,672	63,174 Added 64.04%	161,819 $695,000
Q2 2023 Aug 10, 2023	BUY	$4.19 - $6.16 $413,322 - $607,653	98,645 New	98,645 $541,000
Q1 2022 May 12, 2022	SELL	$5.16 - $7.14 $279,940 - $387,359	-54,252 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$6.37 - $8.18 $95,932 - $123,190	-15,060 Reduced 21.73%	54,252 $382,000
Q3 2021 Nov 12, 2021	BUY	$6.98 - $8.47 $54,088 - $65,634	7,749 Added 12.59%	69,312 $484,000
Q2 2021 Aug 12, 2021	SELL	$5.44 - $8.4 $6,185 - $9,550	-1,137 Reduced 1.81%	61,563 $513,000
Q1 2021 May 13, 2021	SELL	$3.91 - $6.99 $67,834 - $121,269	-17,349 Reduced 21.67%	62,700 $342,000
Q4 2020 Feb 16, 2021	SELL	$3.0 - $4.5 $54,522 - $81,783	-18,174 Reduced 18.5%	80,049 $343,000
Q3 2020 Nov 12, 2020	BUY	$2.75 - $4.2 $135,913 - $207,576	49,423 Added 101.28%	98,223 $296,000
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.14 $6,413 - $9,498	3,025 Added 6.61%	48,800 $151,000
Q1 2020 May 13, 2020	BUY	$1.42 - $3.29 $6,496 - $15,051	4,575 Added 11.1%	45,775 $0
Q4 2019 Feb 12, 2020	SELL	$2.45 - $3.25 $1,225 - $1,625	-500 Reduced 1.2%	41,200 $126,000
Q3 2019 Nov 13, 2019	BUY	$1.59 - $3.47 $66,303 - $144,699	41,700 New	41,700 $128,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

32.3M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $54.5M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Harvard Bioscience Inc Transaction History